Moxonidin Ingen Pharma

Medicinal product

(Invented) name

Moxonidin Ingen Pharma

Active substance (s)

Moksonidinas

Strength

300 µg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C02AC05, Moxonidine

Marketing authorisation holder

SIA Ingen Pharma, Latvija

Date of authorisation

2014-10-16

Date of renewal

2020-02-04

Documents

3639_01-06 pakuotes lapelis_2020-02-04.docx

3639_1-6 Moxonidin_Ingen_Pharma_perr2020-02-04.docx

Moxonidin Ingen Pharma_AR.pdf

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Moksonidinas	300 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
57077	71190	1071190	lizdinė plokštelė	N30		Receptinis	LT/1/14/3639/003	Netiekiama	-	-	No	-	-
60430	74707	1074707	lizdinė plokštelė	N90		Receptinis	LT/1/14/3639/004	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2020-02-04	Perregistruotas
2014-10-16	Registruotas